Franck Meslin

413 total citations
10 papers, 332 citations indexed

About

Franck Meslin is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Franck Meslin has authored 10 papers receiving a total of 332 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Oncology and 5 papers in Immunology. Recurrent topics in Franck Meslin's work include Cell death mechanisms and regulation (4 papers), Immunotherapy and Immune Responses (4 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Franck Meslin is often cited by papers focused on Cell death mechanisms and regulation (4 papers), Immunotherapy and Immune Responses (4 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Franck Meslin collaborates with scholars based in France, China and United States. Franck Meslin's co-authors include Salem Chouaı̈b, Abdelali Jalil, Ahmed Hamaï, Maryam Mehrpour, Catherine Richon, Houssem Benlalam, Florence Faure, Yann Lécluse, Jérôme Thiery and Ping Gao and has published in prestigious journals such as Journal of Biological Chemistry, Cancer Research and Oncogene.

In The Last Decade

Franck Meslin

10 papers receiving 329 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Franck Meslin France 8 204 115 103 38 37 10 332
Manjula Donepudi United States 8 244 1.2× 91 0.8× 94 0.9× 32 0.8× 5 0.1× 8 390
Christie Mortales United States 7 212 1.0× 96 0.8× 227 2.2× 56 1.5× 5 0.1× 9 372
Ana I. Oliveira Portugal 11 272 1.3× 109 0.9× 73 0.7× 148 3.9× 11 0.3× 17 415
Ludmila Jirmanova United States 9 521 2.6× 174 1.5× 96 0.9× 87 2.3× 8 0.2× 12 641
Yukiko Kariya Japan 11 163 0.8× 55 0.5× 74 0.7× 32 0.8× 6 0.2× 12 287
James Schuman United States 9 229 1.1× 111 1.0× 247 2.4× 76 2.0× 6 0.2× 9 422
David Michod Switzerland 14 393 1.9× 104 0.9× 43 0.4× 75 2.0× 7 0.2× 18 488
Brian E. Hsu Canada 7 146 0.7× 162 1.4× 236 2.3× 60 1.6× 16 0.4× 9 425
Tristan Gallenne Netherlands 8 458 2.2× 206 1.8× 89 0.9× 74 1.9× 5 0.1× 14 633
Laura Caputo United States 9 205 1.0× 206 1.8× 292 2.8× 22 0.6× 10 0.3× 13 497

Countries citing papers authored by Franck Meslin

Since Specialization
Citations

This map shows the geographic impact of Franck Meslin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Franck Meslin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Franck Meslin more than expected).

Fields of papers citing papers by Franck Meslin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Franck Meslin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Franck Meslin. The network helps show where Franck Meslin may publish in the future.

Co-authorship network of co-authors of Franck Meslin

This figure shows the co-authorship network connecting the top 25 collaborators of Franck Meslin. A scholar is included among the top collaborators of Franck Meslin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Franck Meslin. Franck Meslin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Meslin, Franck, Ahmed Hamaï, Bernhard Mlecnik, et al.. (2011). hSMG-1 is a granzyme B-associated stress-responsive protein kinase. Journal of Molecular Medicine. 89(4). 411–421. 7 indexed citations
2.
Hamaï, Ahmed, Houssem Benlalam, Franck Meslin, et al.. (2009). Immune surveillance of human cancer: if the cytotoxic T‐lymphocytes play the music, does the tumoral system call the tune?. Tissue Antigens. 75(1). 1–8. 56 indexed citations
3.
Hamaï, Ahmed, Franck Meslin, Houssem Benlalam, et al.. (2008). ICAM-1 Has a Critical Role in the Regulation of Metastatic Melanoma Tumor Susceptibility to CTL Lysis by Interfering with PI3K/AKT Pathway. Cancer Research. 68(23). 9854–9864. 61 indexed citations
4.
Hage, Faten El, et al.. (2008). [Immune response and cancer].. PubMed. 95(1). 57–67. 4 indexed citations
5.
Chouaı̈b, Salem, Franck Meslin, Jérôme Thiery, & Fathia Mami‐Chouaib. (2008). Tumor resistance to specific lysis: A major hurdle for successful immunotherapy of cancer. Clinical Immunology. 130(1). 34–40. 7 indexed citations
6.
Meslin, Franck, Jérôme Thiery, Catherine Richon, Abdelali Jalil, & Salem Chouaı̈b. (2007). Granzyme B-induced Cell Death Involves Induction of p53 Tumor Suppressor Gene and Its Activation in Tumor Target Cells. Journal of Biological Chemistry. 282(45). 32991–32999. 34 indexed citations
7.
André, Fabrice, Rita Nahta, Rosa Conforti, et al.. (2007). Expression patterns and predictive value of phosphorylated AKT in early-stage breast cancer. Annals of Oncology. 19(2). 315–320. 32 indexed citations
8.
Meslin, Franck, Rosa Conforti, Chafika Mazouni, et al.. (2007). Efficacy of adjuvant chemotherapy according to Prion protein expression in patients with estrogen receptor-negative breast cancer. Annals of Oncology. 18(11). 1793–1798. 36 indexed citations
9.
Meslin, Franck, Ahmed Hamaï, Ping Gao, et al.. (2007). Silencing of Prion Protein Sensitizes Breast Adriamycin-Resistant Carcinoma Cells to TRAIL-Mediated Cell Death. Cancer Research. 67(22). 10910–10919. 53 indexed citations
10.
Hamaï, Ahmed, Catherine Richon, Franck Meslin, et al.. (2006). Imatinib enhances human melanoma cell susceptibility to TRAIL-induced cell death: relationship to Bcl-2 family and caspase activation. Oncogene. 25(58). 7618–7634. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Manjula Donepudi Breakdown of academic impact, for papers by Christie Mortales Breakdown of academic impact, for papers by Ana I. Oliveira Breakdown of academic impact, for papers by Ludmila Jirmanova Breakdown of academic impact, for papers by Yukiko Kariya Breakdown of academic impact, for papers by James Schuman Breakdown of academic impact, for papers by David Michod Breakdown of academic impact, for papers by Brian E. Hsu Breakdown of academic impact, for papers by Tristan Gallenne Breakdown of academic impact, for papers by Laura Caputo
Rankless by CCL
2026